MedTrace Logo

Chemoreflex Sensitivity in Chronic Kidney Disease

NCT00794872 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 65

Last updated 2008-11-20

No results posted yet for this study

Summary

Cardiovascular morbidity and mortality are markedly increased in chronic kidney disease (CKD) and may be explained in part by sympathetic hyperactivity. Impaired hyperoxic chemoreflex sensitivity (CHRS) has been attributed to an increased sympathetic activity. The aim of the present study is to examine whether chemosensor function is altered in patients with stage 3 and stage 4 CKD.

Conditions

Interventions

OTHER

blood sampling

Sponsors & Collaborators

  • Heinrich-Heine University, Duesseldorf

    collaborator OTHER

  • SLK Kliniken Heilbronn GmbH

    collaborator OTHER

  • RWTH Aachen University

    lead OTHER

Principal Investigators

  • Christian Meyer, MD · RWTH Aachen University Departement of Cardiology, Pulmonology and Vascular Medicine

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2008-11-30
Completion
2008-11-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00794872 on ClinicalTrials.gov